SCHEMBL5831992

SCHEMBL5831992

Oc1ccc(-c2nc3ccccc3o2)cc1Cl

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.80
ESR1 P03372 6/20 0.72
ESR2 Q92731 6/20 0.72
RAB9A P51151 5/20 0.57
KDM6B O15054 1/20 0.56
KDM6A O15550 1/20 0.56
NPC1 O15118 6/20 0.54
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
ATM Q13315 1/20 0.54
MAPT P10636 3/20 0.53
SNCA P37840 1/20 0.53
KDM4E B2RXH2 4/20 0.51
ALDH1A1 P00352 4/20 0.51
HPGD P15428 4/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
TP53 P04637 3/20 0.51
NFKB1 P19838 2/20 0.50
STAT1 P42224 2/20 0.50
NFKB2 Q00653 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30522740 0.86 RAB9A (0.61) PTGS2ESR1ESR2RAB9ANPC1
SCHEMBL11556101 0.86 RAB9A (0.61) PTGS2ESR1ESR2RAB9ANPC1
SCHEMBL11326079 0.84 PTGS2 (0.62) PTGS2ESR1ESR2RAB9AKDM6B
SCHEMBL1378656 0.84 ESR1 (1.00) PTGS2ESR1ESR2MAPTSNCA
SCHEMBL1376259 0.84 ESR1 (1.00) PTGS2ESR1ESR2RAB9ANPC1
SCHEMBL5832955 0.82 MAPT (0.63) PTGS2RAB9ANPC1MEN1KMT2A
SCHEMBL11320611 0.82 NPC1 (0.59) PTGS2ESR1ESR2RAB9AKDM6B
SCHEMBL3317791 0.81 KDM6B (0.63) PTGS2ESR1ESR2RAB9AKDM6B
SCHEMBL6513627 0.81 ESR2 (0.58) PTGS2ESR1ESR2RAB9ANPC1
SCHEMBL11334046 0.80 RAB9A (0.59) PTGS2ESR1ESR2RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7087601-B2 Metabotropic glutamate receptor-5 modulators MERCK & CO., INC. (US) 2006-08-08 US disclosed
EP-1453815-A4 METABOTROPIC GLUTAMATE RECEPTOR-5 MODULATORS MERCK & CO INC (US) 2005-04-06 EP disclosed
US-20050065340-A1 Metabotropic glutamate receptor-5 modulators MERCK SHARP & DOHME CORP. 2005-03-24 US disclosed
EP-1453815-A1 METABOTROPIC GLUTAMATE RECEPTOR-5 MODULATORS Merck & Co., Inc. (US) 2004-09-08 EP disclosed
WO-2004030637-A2 TREATMENT OF OBESITY AND OTHER DISORDERS ASSOCIATED WITH EXCESSIVE FOOD INTAKE MERCK & CO., INC. (US) 2004-04-15 WO disclosed
WO-2003048137-A1 METABOTROPIC GLUTAMATE RECEPTOR-5 MODULATORS MERCK & CO., INC. (US) 2003-06-12 WO disclosed
US-4256626-A 2-BENZIMIDAZOLYL-, 2-BENZOTHIAZOLYL-, OR 2-INDOLYL-PHENYL DERIVATIVES LINKED TO A 2-HYDROXYBENZOPHENONE EASTMAN KODAK COMPANY (US) 1981-03-17 US disclosed
US-4174321-A POLYMERIC MOLDING MATERIALS EASTMAN KODAK COMPANY (US) 1979-11-13 US disclosed
US-4129723-A Bichromophoric benzoxazole-styrene ester and amide ultraviolet stabilizers and their use in organic compositions EASTMAN KODAK COMPANY (US) 1978-12-12 US disclosed
US-4127501-A BENZOXAZOLE, BENZOTHIAZOLE, BENZIMIDAZOLE, BENZOTRIAZOLE OR INDOLE DERIVATIVES EASTMAN KODAK COMPANY (US) 1978-11-28 US disclosed
US-4115348-A DEGRADATION INHIBITORS EASTMAN KODAK COMPANY (US) 1978-09-19 US disclosed
US-4097606-A N-ACETYL-P-AMINOPHENOL, HIGH ABSORPTION TABLET; ANALGESIC, ANTIPYRETIC BRISTOL-MYERS COMPANY (US) 1978-06-27 US disclosed
US-4062800-A Bichromophoric benzoxazole-styrene ester and amide ultraviolet stabilizers and their use in organic compositions EASTMAN KODAK COMPANY (US) 1977-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065340-A1 Metabotropic glutamate receptor-5 modulators GRM5, GRIK5, GRM1 PTGS2 1019/4885ESR1 773/4885ESR2 644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.